Filter
1831
Filtered Results: 1831
Text search:
World
Health
Organization
WHO
and
World
Intellectual
Property
Organization
Featured
Recommendations
232
New Publications
385
Language
Document type
No document type
657
Studies & Reports
400
Guidelines
365
Manuals
204
Strategic & Response Plan
113
Training Material
52
Fact sheets
27
Situation Updates
7
Resource Platforms
4
Infographics
2
Countries / Regions
Global
153
India
35
South–East Asia Region
28
Africa
27
Western and Central Europe
27
Kenya
26
Ukraine
26
Uganda
23
South Africa
21
Ethiopia
21
Nepal
17
Ghana
17
Eastern Europe and Central Asia
16
Nigeria
14
Asia
14
Myanmar / Burma
13
Sierra Leone
12
West and Central Africa
12
East and Southern Africa
12
Bangladesh
12
Zambia
12
Syria
11
Malawi
11
Indonesia
11
Cambodia
10
Tanzania
10
Liberia
10
Rwanda
9
Middle East and North Africa
9
Western Pacific Region
8
Yemen
7
South Sudan
7
Lesotho
6
Afghanistan
6
Philippines
6
Eastern Europe
6
Thailand
5
Cameroon
5
Zimbabwe
5
Guinea
5
Mozambique
5
Latin America and the Carribbean
5
Congo, Democratic Republic of
5
Somalia
5
Pakistan
5
Haiti
4
Vietnam
4
Russia
4
Sudan
4
North Macedonia
3
Tajikistan
3
Kazakhstan
3
Iran
3
Laos
3
Burkina Faso
3
Germany
3
Lebanon
3
Colombia
2
Timor Leste/ East Timor
2
China
2
Kyrgyzstan
2
Peru
2
Venezuela
2
Lithuania
2
Jordan
2
Saudi Arabia
2
Côte d’Ivoire / Ivory Coast
2
Sri Lanka
2
Djibouti
2
Palestine
2
Georgia
2
Angola
2
Botswana
2
Iraq
2
Ecuador
2
North Korea
1
Mexico
1
Serbia
1
Turkey
1
Chile
1
Albania
1
Canada
1
Senegal
1
Estonia
1
Uzbekistan
1
Morocco
1
Mongolia
1
Qatar
1
Bulgaria
1
Armenia
1
USA
1
Paraguay
1
Japan
1
Denmark
1
Mauritius
1
Tunisia
1
Azerbaijan
1
Belarus
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Namibia
1
Egypt
1
Greece
1
Mali
1
Chad
1
Libya
1
Bhutan
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
355
Clinical Guidelines
232
Public Health
170
Key Resources
136
Women & Child Health
134
Capacity Building
54
Pharmacy & Technologies
44
Toolboxes
Mental Health
184
COVID-19
148
HIV
143
Disability
141
TB
101
Caregiver
89
NTDs
86
Planetary Health
85
AMR
71
Rapid Response
70
Global Health Education
56
Pharmacy
42
NCDs
42
Conflict
42
Health Financing Toolbox
29
Refugee
20
Ebola & Marburg
17
Specific Hazards
10
Natural Hazards
9
Social Ethics
8
Polio
7
Malaria
4
Zika
4
Cholera
3
This training module is designed to equip health workers (HWs) with
knowledge, skills, confidence and resources to help them in their role to recommend the Human Papillomavirus
(HPV) vaccine.
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
One important application of digital health in TB patient care is the support that it can lend to medication adherence. TB programmes have already been using short message service (SMS), video-supported treatment (VOT) and event monitoring device for medication support ...
This document provides a generic model that can be used for risk assessment of exposure to insecticide products applied as indoor residual sprays. It aims to harmonize the risk assessment of such insecticides for public health use in order to generate comparable data for their registering and labell...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
A framework for action provides a guide for those involved in the development of the multisectoral action plan. It starts with a wide-ranging vision and, through a series of increasingly specific intentions, brings into focus actions with measurable outcomes that can be taken to achieve that vision.
The recommendations cover the level of blood pressure to start medication, what type of medicine or combination of medicines to use, the target blood pressure level, and how often to have follow-up checks on blood pressure. In addition, the guideline provides the basis for how physicians and other h...
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
These country profiles present progress on implementation of policy recommendations of the Global Action Plan on Physical Activity (GAPPA) 2018-2030 in each country. They also present an estimate of the cost to health systems of not taking action to improve physical activity levels and reinforce th...
One of the first steps in developing a multisectoral action plan (MSAP) is to use a situation analysis to provide a comprehensive assessment of the health needs, prevailing risks and the context of the area to which the plan will apply. This will help countries, regions, provinces or cities intendi...
This manual will aid in building the capacity of nurses with clinical knowledge of the unique needs, complex health problems, common geriatric syndromes, and principles of care of older people. It will also enable them to acquire the skills necessary to perform an in-depth multidimensional geriatric...
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
The WHO Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR) was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID...
This report presents key findings from a study carried out on the ‘Mainstreaming quality of care in empanelled hospitals under PMJAY’. It provides a detailed analysis of current coverage and perceptions of quality accreditation and certification across PMJAY empanelled hospitals from three diffe...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
This document summarizes the results of the WHO-commissioned full value proposition for new tuberculosis (TB) vaccines. The assessment was commissioned to provide early evidence for national and global decision-makers involved in TB vaccine development and implementation, who include stakeholders in...
This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national pu...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
